ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer.

Hui Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.